Resources for You
Nutropin (Somatropin [rDNA origin]) Injection
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2012
WARNINGS AND PRECAUTIONS
- Cases of pancreatitis have been reported rarely in children and adults receiving somatropin treatment, with some evidence supporting a greater risk in children compared with adults. Published literature indicates that girls who have TS may be at greater risk than other somatropin-treated children. Pancreatitis should be considered in any somatropin–treated patient, especially a child, who develops persistent severe abdominal pain.
Most Serious and/or Most Frequent Observed Adverse Reactions
- Pancreatitis [see Warnings and Precautions (5.15)]